Author: Biotech Express

In a scientific first, researchers at Israel’s Weizmann Institute of Science have successfully created synthetic models of 14-day-old human embryos derived entirely from stem cells grown in a lab. The breakthrough, reported in the journal Nature, provides an unprecedented glimpse into the mysterious earliest stages of human development and could open up new avenues of research into infertility, birth defects, and organ growth. Led by molecular biologist Professor Jacob Hanna, the Weizmann team started with two types of stem cells – those reprogrammed from adult skin cells and others derived from established lab-grown stem cell lines. Using a specialised technique…

Concord Biotech Ltd initial public offering (IPO) opens for subscription on Friday, August 4, and closes on Tuesday, August 8. The allocation to anchor investors for Concord Biotech IPO is scheduled to take place on Thursday, August 3. Concord Biotech IPO price band has been fixed in the range between ₹705 to ₹741 per equity share of face value of ₹1 each. Concord Biotech IPO lot size is 20 equity shares and in multiples of 20 equity shares thereafter. 20% of the company is owned by Helix Investment Holdings Pte Ltd, which is backed by Quadria Capital Fund LP, an Asian private equity fund with…

It was 2018 when the nation first heard about National Research Foundation(NRF) through a speech by Prime minister of India in Indian science congress. Later it was recalled by finance minister N Sitharaman in budget session of July 2019 when she said that the creation of NRF was also one of the key recommendations of the National Education Policy 2020. Again in June 2023 NRF became the topic of discussion when legislation was put on table in the current monsoon session of Parliament. Though the papers describing its detail are not available in public domain, various govt and non govt…

Biodiversity is the diversity of life. If we are more diversified we are more absorbed in work and reduces risks, similarly diversity in nature protects it. Today there are around 8 to 20 million or more kinds of organisms in which the genetic material is in the form of chromosomes that are contained within distinct cells and called Eukaryotes. Of them, only few million have been recognised and named. There are, in addition, much larger number of unknown prokaryotes, consisting of archaea and bacteria. Biodiversity has several dimensions, these include different variety of living organisms, the genes they contain and…

Rajesh Gokhale Monday took over as the Secretary, Department of Science and Technology (DST). This will be an additional charge as he is currently serving as the Secretary, Department of Biotechnology (DBT), a position held since October 2021. Last month, the union government announced that S. Chandrasekhar , the incumbent DST Secretary, will be relieved from his services and will return to his parent institute in Hyderabad, in the Council of Scientific and Industrial Research (CSIR). His appointment was originally till the end of 2023. Dr Gokhale (born 16/01/1967) did his graduation in B.Sc. Chemistry from Delhi University and M.Sc.…

by Amit Chopra, Managing Director, India & South Asia, Thermo Fisher Scientific The onset of monsoons in India provides relief from the intense heat, but it also brings a concurrent rise in allergies. Triggered by immunoglobulin E (IgE), an allergy is an exaggerated immune response, to substances such as particulate matter and pollen, specific types of foods and medications. Although allergies are generally non-life-threatening and can be managed with medications, their growing prevalence has become a major global health concern, impacting millions. Allergies are now ranked as the sixth leading cause of chronic diseases worldwide, posing complex challenges for individuals…

In the inspiring presence of Chief Minister Shri Bhupendra Patel in Gandhinagar on Wednesday, July 19th, the stakeholders of the Biotechnology Policy accomplished a remarkable feat by concluding MoUs worth ₹2000 crore in a single day for new investments in the state’s biotechnology sector. The MoU was signed by Science Technology Secretary Shri Vijay Nehra on behalf of the State Government. Approximately 3,000 jobs are set to be created in the upcoming biotech industries as a result of this MoU. It was signed by a total of 15 companies, with 13 from Gujarat, and one from Maharashtra and one from…

Pune-based Enzene Biosciences  announced that it has launched Cetuximab as the first biosimilar to cancer. Sold under the brand name Erbitux, Cetuximab is a therapeutic chimeric monoclonal antibody that is used as a targeted therapy for metastatic colorectal Cancer (mCRC) and cancer of the head and neck, with eight weeks of treatment costing about $30,000 for a single patient. However, after past patent expiry, several companies were in the race to develop “Cetuximab’s biosimilar in order to bring down the costs of treatment. Enzene Biosciences has earned the distinction of being the first company to achieve this goal, thereby leading…

Ambiq®, a technology leader in ultra-low power semiconductor products and solutions, introduces the Apollo4 Lite and Apollo4 Blue Lite SoC to its expanding portfolio of SoCs for IoT endpoint devices, especially the remote monitoring products of the healthcare sector. This announcement follows Ambiq’s release of its Heart Kit™, an optimized open-source AI model utilizing multi-head neural networks (MH-NNs) to enable a variety of real-time heart-monitoring applications. The Apollo4 Lite and Blue Lite product line is the latest generation system processor solutions built upon Ambiq’s proprietary Subthreshold Power-Optimized Technology (SPOT®) platform, enabling new features while reducing devices’ overall system power consumption…

BMJ Open has retracted a paper describing a study in which people with diabetes will be switched from cigarettes to vaping after the journal learned – late in the process of publication – that the authors were indirectly funded by the tobacco company, Philip Morris International. The paper, “International randomised controlled trial evaluating metabolic syndrome in type 2 diabetic cigarette smokers following switching to combustion-free nicotine delivery systems: the DIASMOKE protocol,” was originally published on April 1, 2021. Its retraction notice, dated June 20, 2023, reads: This article has been retracted by the journal and publisher following a post-publication review…